RRM2 and familial pancreatic carcinoma: Finally, RRM2 may not be a global determinant of drug-resistance in pancreatic cancer cells, in which case the proposed let-7-RRM2-chemoresistance axis may not be as effective as expected in RRM2-dependent resistance.